A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Clinical trial NCT00006154 · COMPLETED
Trial details
- NCT number
- NCT00006154
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.